Skip to main content

Peer Review reports

From: Optimization of acute medication use following eptinezumab initiation during a migraine attack: post hoc analysis of the RELIEF study

Original Submission
21 Jun 2022 Submitted Original manuscript
1 Jul 2022 Reviewed Reviewer Report - Mahsa Babaei
2 Jul 2022 Reviewed Reviewer Report
15 Jul 2022 Author responded Author comments - Anders Ettrup
Resubmission - Version 2
15 Jul 2022 Submitted Manuscript version 2
18 Jul 2022 Editorially accepted
28 Jul 2022 Article published 10.1186/s10194-022-01463-3

You can find further information about peer review here.

Back to article page